![]() |
市場調查報告書
商品編碼
1831939
2025-2033 年筆式針頭市場報告(按類型、針頭長度、療法、購買方式、最終用戶和地區)Pen Needles Market Report by Type, Needle Length, Therapy, Mode of Purchase, End User, and Region 2025-2033 |
2024年,全球注射筆針頭市場規模達42億美元。展望未來, IMARC Group預計到2033年,市場規模將達到118億美元,2025-2033年期間的複合年成長率(CAGR)為12.2%。糖尿病和慢性病盛行率上升、老年人口成長、醫療保健領域投資增加、技術快速進步、胰島素自行注射的普及以及優惠報銷政策的實施,這些因素共同推動著市場的發展。
糖尿病和其他慢性疾病的盛行率不斷上升
全球糖尿病和其他慢性病的盛行率不斷上升是推動注射筆針頭市場成長的主要因素。根據國際糖尿病聯盟 (IDF) 的《糖尿病地圖集》,2021 年,20 至 79 歲成年人口中 10.5% 患有糖尿病,超過一半的人不知道自己被診斷出患有糖尿病。預測顯示,到 2045 年,每八個成年人中就有一人(即近 7.83 億人)將罹患糖尿病,增幅約 46%。因此,糖尿病管理需要頻繁監測和注射胰島素,而這可以透過配備注射筆針頭的胰島素筆來實現。對於需要頻繁注射胰島素的糖尿病患者來說,注射筆針頭因其簡單易用而成為不可或缺的工具。
老年人口不斷擴大
筆式注射針市場預測強調,老年人口的成長是推動該市場成長的重要因素。由於與年齡相關的生理變化和更高的合併症盛行率,老年人更容易患上糖尿病等慢性疾病。根據世界衛生組織 (WHO) 預測,到 2050 年,全球 60 歲以上人口的比例預計將從 2015 年的 12% 增加近一倍至 22%。這種人口結構變化對醫療保健系統和醫療器材需求有著深遠的影響。此外,設計有易於操作、疼痛最小化和安全性機制等特點的筆式注射針對這個年齡層的人也大有裨益。隨著老年人口的持續成長,對滿足其特定需求的產品的需求預計將增加,從而推動市場擴張。
醫療保健領域投資不斷成長
多個國家加大對醫療保健產業的投入,增強了注射筆針頭的市場佔有率。例如,2022 年,歐洲政府在衛生方面的整體支出為 1,2,210 億歐元,佔 GDP 的 7.7%。同樣,印度的公共醫療保健支出在 2023 會計年度佔 GDP 的 2.1%,在 2022 會計年度佔 GDP 的 2.2%。這種擴張使得糖尿病等疾病的診斷、監測和管理得到改善,從而推動了對注射筆針頭的需求。此外,具有成本效益的保險覆蓋和報銷計劃的可用性一直在鼓勵患者探索使用胰島素筆和注射筆針頭作為治療選擇。例如,2022 年期間,92.1% 的人(即美國的 3.04 億人)在某個時候擁有健康保險,這也增加了對注射筆針頭的需求。
標準筆針佔據大部分市場佔有率
根據注射筆針頭市場前景與分析,標準注射筆針頭佔據最大佔有率,這得益於其在患者和醫護人員中的廣泛使用和認可。這些針頭設計適用於大多數胰島素筆,並以其多功能性、易用性以及多種長度和規格的供應而聞名。此外,標準注射筆針頭因其成本效益高以及與各種胰島素輸送系統相容的廣泛選擇而受到青睞。此外,設計和技術的不斷改進提高了注射時的舒適度並減輕了疼痛,這也對注射筆針頭的市場價值產生了積極影響。
8mm佔據行業最大佔有率
根據注射筆針頭市場報告及趨勢,8毫米針頭長度佔據最大市場佔有率,這歸功於其均衡的療效和舒適度,適用於各類患者。此長度被認為是皮下胰島素輸送的最佳選擇,既能確保胰島素充分滲透皮下組織,又能最大限度地降低肌肉注射的風險。此外,8毫米針頭因其多功能性而受到醫療保健提供者的廣泛推薦,適合成人和兒童使用。此外,8毫米針頭在臨床實踐中的廣泛使用,加上患者的熟悉度和接受度,正在擴大注射筆針頭的市場規模。
胰島素佔據主要市場佔有率
根據注射筆針頭市場概況和細分,胰島素治療佔據最大佔有率,這得益於糖尿病患病率的不斷上升以及有效管理疾病的胰島素注射的必要性。因此,胰島素治療需要頻繁且精準的注射,這使得注射筆針頭成為糖尿病患者的必備工具。此外,注射筆針頭的便利性、準確性和疼痛減輕等特性的提升,提高了患者的依從性和生活品質,也促進了市場的成長。此外,先進胰島素筆的研發和產品技術的持續創新也支撐了注射筆針頭市場的價格趨勢。
零售業在市場上佔據明顯主導地位
根據筆式針頭市場研究報告,零售市場佔據了最大佔有率,這得益於其為消費者提供的便利性和可及性。零售藥局和線上商店為患者提供了便捷的即時獲取管道,因為它們可以快速提供所需物資,無需前往醫療機構。此外,零售通路的廣泛分銷網路確保了廣泛的供應,滿足了城鄉居民的需求。此外,零售店提供各種品牌和產品,使患者能夠選擇最符合其需求和偏好的筆式針頭。
醫院和診所佔據市場主導地位
醫院和診所構成了最大的細分市場,這得益於這些場所進行的大量醫療程序和慢性病管理。它們是主要的醫療保健提供者,大量糖尿病患者在這裡接受診斷、制定治療計劃和持續管理,因此需要穩定的注射筆針頭供應,用於胰島素注射和其他注射療法。此外,這些醫療機構優先考慮患者的安全和療效,選擇高品質的針頭,以確保精準舒適的藥物輸送。此外,醫院和診所是患者正確使用這些針頭的首要教育場所,這推動了市場的成長。
歐洲引領市場,佔據注射筆針頭最大市場佔有率
該報告還對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告指出,歐洲是筆式針頭最大的區域市場。
歐洲佔據著注射筆針頭產業最大的市場佔有率,這得益於高糖尿病盛行率、先進的醫療基礎設施以及政府的支持政策。同時,強大的醫療保健體系提供了廣泛的糖尿病管理工具,加上強力的報銷框架的支持,減輕了患者的經濟負擔,這些因素正在推動市場成長。此外,人們對糖尿病照護的認知度高,積極進行公共衛生活動和推廣注射筆針頭的教育項目,也有利於市場成長。此外,多家領先的醫療器材製造商積極推動創新,並推動先進針頭技術的普及,也刺激了注射筆針頭市場的收入成長。
市場研究報告還對市場競爭格局進行了全面分析,並提供了所有主要公司的詳細資料。筆式針頭行業的一些主要市場參與者包括:
主要的注射筆針頭公司正致力於創新、策略合作以及拓展全球業務,以維持並提升其市場地位。他們專注於透過超細和更短的針頭進行創新,以提高患者的舒適度和依從性。此外,一些公司正利用其在胰島素輸送市場的強大影響力,將先進的注射筆針頭與胰島素筆整合,以確保無縫有效的糖尿病管理。此外,他們還致力於透過技術先進的解決方案擴展產品組合,並增強分銷網路以覆蓋更廣泛的受眾。此外,這些公司也積極參與策略合作和收購,以增強其市場地位和能力。
The global pen needles market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.8 Billion by 2033, exhibiting a growth rate (CAGR) of 12.2% during 2025-2033. The market is driven by the rising prevalence of diabetes and chronic diseases, expanding geriatric population, increasing investment in the healthcare sector, rapid technological advancements, growing self-administration of insulin, and the imposition of favorable reimbursement policies.
Increasing Prevalence of Diabetes and Other Chronic Diseases
The rising prevalence of diabetes and other chronic diseases across the globe is a major factor driving the pen needles market growth. According to the International Diabetes Federation's (IDF) Diabetes Atlas, 10.5% of the adult population aged 20 to 79 had diabetes in 2021, with over half unaware of the diagnosis. By 2045, this forecast predicts that one in every eight adults, or nearly 783 million, will have diabetes, which is an approximately 46% rise. In line with this, diabetes management necessitates frequent monitoring and insulin administration, which is accomplished with insulin pens equipped with pen needles. Pen needles are an indispensable tool for diabetes patients who require frequent insulin injections due to their ease and user-friendliness.
Expanding Geriatric Population
The pen needles market forecast highlights that the expanding geriatric population is a significant factor that is resulting in the growth of this market. Geriatric adults are more susceptible to chronic diseases, including diabetes, due to age-related physiological changes and a higher prevalence of comorbidities. According to the World Health Organization (WHO), the proportion of the world's population over 60 years is projected to nearly double from 12% in 2015 to 22% by 2050. This demographic shift has profound implications for healthcare systems and the demand for medical devices. Additionally, pen needles that are designed with features like easy handling, minimal pain, and safety mechanisms are beneficial for this age group. As the geriatric population continues to grow, the demand for products that are tailored to their specific needs is expected to increase, driving the expansion of the market.
Growing Investment in the Healthcare Sector
The increasing funding in the healthcare industry by several countries is strengthening the pen needle market share. For example, in 2022, Europe's overall government spending on health totaled €1221 Billion, or 7.7% of GDP. Similarly, India's public healthcare spending accounted for 2.1% of GDP in FY23 and 2.2% in FY22. This expansion has been allowing for improved diagnosis, monitoring, and management of illnesses such as diabetes, which drives up the demand for pen needles. Furthermore, the availability of cost-effective insurance coverage and reimbursement schemes have been encouraging patients to explore the use of insulin pens and pen needles as a treatment option. For instance, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during 2022, which also increased the pen needles demand.
Standard pen needles accounts for the majority of the market share
As per the pen needles market outlook and analysis, the standard pen needles segment represented the largest share, driven by their widespread usage and acceptance among patients and healthcare providers. These needles are designed to fit most insulin pens and are known for their versatility, ease of use, and availability in various lengths and gauges. Moreover, standard pen needles are preferred due to their cost-effectiveness and the broad range of options that ensure compatibility with various insulin delivery systems. Besides this, the continuous improvements in design and technology, which enhance comfort and reduce pain during injections, are positively impacting the pen needle market value.
8mm holds the largest share of the industry
Based on the pen needles market report and trends, the 8mm needle length segment holds the largest share in the market, attributed to its balanced efficacy and comfort for a wide range of patients. This length is considered optimal for subcutaneous insulin delivery, ensuring adequate penetration to the subcutaneous tissue while minimizing the risk of intramuscular injection. Moreover, the 8mm needles are widely recommended by healthcare providers due to their versatility, making them suitable for adults and children. Along with this, the extensive use of 8mm needles in clinical practice, coupled with patient familiarity and acceptance, is enhancing the pen needles market size.
Insulin represents the leading market segment
According to the pen needles market overview and segmentation, insulin therapy constituted the largest share, driven by the growing prevalence of diabetes and the necessity of insulin administration for effective disease management. In line with this, insulin therapy requires frequent and precise injections, making pen needles an essential tool for diabetic patients. Moreover, the rising convenience, accuracy, and reduced pain associated with pen needles that enhance patient compliance and quality of life are contributing to the market growth. Additionally, the development of advanced insulin pens and continuous innovations in product technology are supporting the pen needle market price trends.
Retail exhibits a clear dominance in the market
As per the pen needles market research report, the retail segment represented the largest share, driven by the convenience and accessibility it offers to consumers. Retail pharmacies and online stores provide an easy and immediate access point for patients as they offer quick supplies without the need for a medical facility visit. Besides this, the broad distribution networks of retail channels ensure widespread availability, catering to urban and rural populations. Additionally, retail outlets offer a variety of brands and products, allowing patients to choose pen needles that best meet their needs and preferences.
Hospitals and clinics dominate the market
Hospitals and clinics constituted the largest segment, driven by the high volume of medical procedures and chronic disease management performed in these settings. They are primary healthcare providers where a significant number of diabetes patients receive their diagnosis, treatment plans, and ongoing management, necessitating a steady supply of pen needles for insulin administration and other injectable therapies. Moreover, these healthcare facilities prioritize patient safety and efficacy, opting for high-quality needles to ensure precise and comfortable medication delivery. Additionally, hospitals and clinics serve as the first point of education for patients on the correct use of these needles, boosting the market growth.
Europe leads the market, accounting for the largest pen needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for pen needles.
Europe holds the largest segment in the pen needles industry, driven by a combination of high diabetes prevalence, advanced healthcare infrastructure, and supportive government policies. In line with this, the robust healthcare systems that provide extensive access to diabetes management tools, coupled with increased support from strong reimbursement frameworks that reduce the financial burden on patients, are boosting the market growth. Along with this, the high awareness of diabetes care, with proactive public health campaigns and educational programs that promote the use of these pens, is favoring the market growth. Additionally, the presence of several leading medical device manufacturers that foster innovation and boost the availability of advanced needle technologies is stimulating the pen needle market revenue.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the pen needles industry include:
The major pen needle companies are focusing on innovation, strategic partnerships, and expanding their global footprint to maintain and enhance their market positions. They are focusing on innovating with ultra-fine and shorter needles to improve patient comfort and compliance. Moreover, some players are leveraging their strong presence in the insulin delivery market to integrate advanced pen needles with their insulin pens to ensure seamless and effective diabetes management. Besides this, they are working on expanding their product portfolio with technologically advanced solutions and enhancing distribution networks to reach a broader audience. Moreover, these companies are actively involved in strategic collaborations and acquisitions to strengthen their market presence and capabilities.